Sectoral Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Sectoral Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,300	Closed	-$185K	–	139
2021 Q1	$185K	Sell	25,300 -1,125,875	-98%	-$9.71M	0.01%	113
2020 Q4	$6.64M	Buy	1,151,175 +1,051,175	+1,051%	+$6.02M	0.47%	64
2020 Q3	$594K	Sell	100,000 -50,000	-33%	-$247K	0.05%	86
2020 Q2	$773K	Buy	+150,000	New	+$947K	0.07%	112
2018 Q4	–	Sell	-3,600	Closed	-$119K	–	159
2018 Q3	$119K	Buy	+3,600	New	+$92.5K	0.01%	154

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sectoral Asset Management's AVEO Position: Q2 2021 in Review

Sectoral Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2021, closing a stake of 25,300 shares — an estimated $185K sold.

Sectoral Asset Management first reported a position in AVEO in Q3 2018 and held it in 5 quarters. The position peaked at $6.64M in Q4 2020. 63 funds tracked by Wall St. Rank hold AVEO as of Q2 2021.

Sectoral Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Sectoral Asset Management sold 25,300 AVEO Pharmaceuticals, Inc. shares in Q2 2021, an estimated $185K.
Sectoral Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2018 and held it in 5 quarters.
Sectoral Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $6.64M in Q4 2020.
63 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2021.

Based on Sectoral Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.